Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham PlcfiledCriticalSmithkline Beecham Plc
Publication of MA26758A1publicationCriticalpatent/MA26758A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
"Composition nouvelle, à libération modifiée, pour le traitement du diabète" L'invention concerne une composition pharmaceutique à libération modifiée. Cette composition comprend un sensibilisant à l'insuline, un autre agent antidiabétique et un support pharmaceutiquement acceptable. Application : utilisation de cette composition pour le traitement du diabète.
MA26192A1998-11-122001-05-11Composition nouvelle, a liberation modifiee, pour le traitement du diabete.
MA26758A1
(fr)
Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade